Cannabidiol: Barriers to Research and Potential Medical Benefits
National Institute of Health
Recently, the National Institute on Drug Abuse (NIH) issued a letter to the Senate Caucus on International Drug Control discussing the potential benefits of Cannabidiol (CBD) and the current “barriers to research.” the following is an excerpt from that letter:
"Rigorous clinical studies are still needed to evaluate the clinical potential of CBD for specific conditions. However, pre-clinical research (including both cell culture and animal models) has shown CBD to have a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties"
More research needs to be done; it should be in the Federal Government’s best interest to facilitate further studies and research of CBD and it’s potential benefits.